GGrantIndex
← Leaderboards

Andrea J. Apter

University Of Pennsylvania

$11,362,038
Attributed
$13,335,035
Total exposure
9
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200523
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$13,335,035 · 9

By mechanism

R01$7,532,923 · 2
R18$3,563,808 · 1
RC1$1,013,230 · 1
K23$650,970 · 1
K02$526,095 · 1
M01$48,009 · 3

Top collaborators

Most similar at University Of Pennsylvania

Same institution · by research overlap

Others in their field

Top investigators on “Asthma

Research focus

AsthmaClinical ResearchInhalation Drug AdministrationHuman SubjectClinicCommunicationAdultMinorityCaringLow IncomeQuality Of LifeVisitBaseSocioeconomicsHospitalizationMonitorCostAffectAttentionChronic DiseaseProviderRandomizedFocus GroupsRandomized Controlled Trials

Grant awards (43)

Clinic navigation and home visits to improve guideline-based care and outcomes in low income minority adults with asthma$755,712
R01 · FY2023 · HL · contact PI
Clinic navigation and home visits to improve guideline-based care and outcomes in low income minority adults with asthma$775,153
R01 · FY2022 · HL · contact PI
Clinic navigation and home visits to improve guideline-based care and outcomes in low income minority adults with asthma$786,116
R01 · FY2021 · HL · contact PI
Clinic navigation and home visits to improve guideline-based care and outcomes in low income minority adults with asthma$799,270
R01 · FY2020 · HL · contact PI
Clinic navigation and home visits to improve guideline-based care and outcomes in low income minority adults with asthma$829,744
R01 · FY2019 · HL · contact PI
A Patient Advocate to improve real-world asthma management for inner city adults$682,342
R18 · FY2017 · HL · contact PI
A Patient Advocate to improve real-world asthma management for inner city adults$720,146
R18 · FY2016 · HL · contact PI
A Patient Advocate to improve real-world asthma management for inner city adults$726,347
R18 · FY2015 · HL · contact PI
A Patient Advocate to improve real-world asthma management for inner city adults$741,378
R18 · FY2014 · HL · contact PI
A Patient Advocate to improve real-world asthma management for inner city adults$693,595
R18 · FY2013 · HL · contact PI
Literacy and improving patient-clinician encounters for Asthma$105,219
K02 · FY2011 · HL · contact PI
A Patient Advocate and Literacy-Based Treatment of Asthma$507,675
RC1 · FY2010 · HL · contact PI
Literacy and improving patient-clinician encounters for Asthma$105,219
K02 · FY2010 · HL · contact PI
Individualized Interventions to Improve Asthma Adherence$679,887
R01 · FY2009 · HL · contact PI
A Patient Advocate and Literacy-Based Treatment of Asthma$505,555
RC1 · FY2009 · HL · contact PI
Literacy and improving patient-clinician encounters for Asthma$105,219
K02 · FY2009 · HL · contact PI
Individualized Interventions to Improve Asthma Adherence$9,178
R01 · FY2009 · HL · contact PI
Individualized Interventions to Improve Asthma Adherence$666,233
R01 · FY2008 · HL · contact PI
Literacy and improving patient-clinician encounters for Asthma$105,219
K02 · FY2008 · HL · contact PI
Individualized Interventions to Improve Asthma Adherence$682,335
R01 · FY2007 · HL · contact PI
Literacy and improving patient-clinician encounters for Asthma$105,219
K02 · FY2007 · HL · contact PI
Individualized Interventions to Improve Asthma Adherence$767,118
R01 · FY2006 · HL · contact PI
Individualized Interventions to Improve Asthma Adherence$782,177
R01 · FY2005 · HL
INHALED STEROID ADHERENCE IN MODERATE &SEVERE ASTHMA$130,194
K23 · FY2004 · HL
Adherence to Inhaled Steroids in Moderate and Severe Asthma$1,065
M01 · FY2004 · RR
INHALED STEROID ADHERENCE IN MODERATE &SEVERE ASTHMA$130,194
K23 · FY2003 · HL
INHALED STEROID ADHERENCE IN MODERATE &SEVERE ASTHMA$130,194
K23 · FY2002 · HL
ELECTRONIC MONITORING IN ASTHMA: IMPROVING ADHERENCE$0
M01 · FY2002 · RR
RISK OF OSTEOPOROSIS ASSOCIATED WITH INHALED GLUCOCORTICOIDS$0
M01 · FY2002 · RR
INHALED STEROID ADHERENCE IN MODERATE &SEVERE ASTHMA$130,194
K23 · FY2001 · HL
ELECTRONIC MONITORING IN ASTHMA: IMPROVING ADHERENCE$4,361
M01 · FY2001 · RR
RISK OF OSTEOPOROSIS ASSOCIATED WITH INHALED GLUCOCORTICOIDS$4,361
M01 · FY2001 · RR
ELECTRONIC MONITORING IN ASTHMA: IMPROVING ADHERENCE$0
M01 · FY2001 · RR
ELECTRONIC MONITORING IN ASTHMA: IMPROVING ADHERENCE$0
M01 · FY2001 · RR
RISK OF OSTEOPOROSIS ASSOCIATED WITH INHALED GLUCOCORTICOIDS$0
M01 · FY2001 · RR
RISK OF OSTEOPOROSIS ASSOCIATED WITH INHALED GLUCOCORTICOIDS$0
M01 · FY2001 · RR
INHALED STEROID ADHERENCE IN MODERATE &SEVERE ASTHMA$130,194
K23 · FY2000 · HL
ELECTRONIC MONITORING IN ASTHMA: IMPROVING ADHERENCE$19,111
M01 · FY2000 · RR
RISK OF OSTEOPOROSIS ASSOCIATED WITH INHALED GLUCOCORTICOIDS$19,111
M01 · FY2000 · RR
ELECTRONIC MONITORING IN ASTHMA: IMPROVING ADHERENCE$0
M01 · FY2000 · RR
ELECTRONIC MONITORING IN ASTHMA: IMPROVING ADHERENCE$0
M01 · FY2000 · RR
RISK OF OSTEOPOROSIS ASSOCIATED WITH INHALED GLUCOCORTICOIDS$0
M01 · FY2000 · RR
RISK OF OSTEOPOROSIS ASSOCIATED WITH INHALED GLUCOCORTICOIDS$0
M01 · FY2000 · RR